Who owns Lundbeck Pharmaceuticals?

Who owns Lundbeck Pharmaceuticals?

Hans Lundbeck

Type Aktieselskab
Founder Hans Lundbeck
Headquarters Copenhagen, Denmark
Key people Deborah Dunsire (CEO) Lars Rasmussen (Chairman) Lene Skole (Vice Chairman)
Revenue DKK 17.2 billion (2017)

What does Lundbeck do?

Lundbeck is a Global Pharmaceutical Company Specialized in Brain Diseases. We are tirelessly dedicated to restoring brain health, so every person can be their best. To fulfill this purpose, Lundbeck is engaged in the research, development, manufacturing and commercialization of pharmaceuticals across the world.

What does Lundbeck make?

Lundbeck is a specialty pharmaceutical company located in Denmark that concentrates on marketing, developing, and producing medications to assist in the treatment of neurological and psychiatric disorders.

Is Lundbeck publicly traded?

Lundbeck is an individual entity, listed on the Copenhagen stock exchange, with its own governance structure and its own executive management and board of directors.

How many employees does Lundbeck have?

Lundbeck/Number of employees

How many employees does Astellas Pharma have?

Astellas Pharma

Type Public (K.K)
Total assets $14.86 billion (2016)
Number of employees 17,217 (2016)
Subsidiaries Astellas US
Website www.astellas.com/en/

Who makes Lexapro stock?

Escitalopram was approved in 2002, and it has been manufactured and marketed by U.S.-based Forest Laboratories Inc., in partnership with the Danish drug company Lundbeck.

What are side effects of Cipralex?

Like all medicines, Cipralex can cause side effects. The most common (may affect more than 1 in 10 people) side effects are nausea and headache….Common

  • Abnormal dreams.
  • Aching muscles or joints.
  • Anxiety.
  • Blocked or runny nose.
  • Decreased or increased appetite and weight gain.
  • Difficulty sleeping.
  • Dry mouth.
  • Increased sweating.